GlassScriptPhysician profile
Jamie H Kapner
NPI 1548255516
$2,786.65
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $375 · 2021: $484 · 2022: $376 · 2023: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,495.75 | 2019-2020 | |
| Teleflex LLC | $474.47 | 2021-2023 | Urolift |
| Astellas Pharma US INC | $180.39 | 2021-2022 | |
| Medical Device Business Services, INC. | $128.60 | 2023 | Vistaseal |
| Axonics, INC. | $77.60 | 2021 | |
| Urogen Pharma, INC. | $74.10 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $54.94 | 2019-2022 | |
| Coloplast Corp | $54.94 | 2020-2021 | |
| Pfizer INC. | $51.58 | 2020 | |
| 180 Medical, INC. | $28.80 | 2020 | |
| Abbvie INC. | $26.74 | 2020 | |
| Myovant Sciences INC. | $26.46 | 2021 | |
| Merck Sharp & Dohme LLC | $24.48 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.76 | 2020 | |
| Tolmar, INC. | $22.51 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $14.99 | 2022 | |
| Laborie Medical Technologies Corp. | $14.78 | 2020 | |
| Convatec INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Kapner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.